A new paradigm for gene therapy
Interviewee/Contributor
Peter Marks
Organisation
US Food and Drug Administration
Research Directory
Novel antifungals set for market introduction
Interviewee/ContributorPeter CharlishOrganisationMedNousLive biotherapeutics change the pharma landscape
Interviewee/ContributorDuncan PeytonOrganisation4D pharma PlcASCO 2021- Oncology developers disclose their latest data
Interviewee/ContributorVictoria EnglishOrganisationMedNousPharma invests in R&D across a broad front
Interviewee/ContributorVictoria English and Jean-Claude MullerOrganisationMedNousOncology approvals rise, driven by novel compounds
Interviewee/ContributorBruno PagliaraOrganisationMedNousHot targets in immuno-oncology
Interviewee/ContributorEliot ForsterOrganisationF-star Therapeutics IncInsect-derived peptides - next generation antibiotics?
Interviewee/ContributorMoshik Cohen-Kutner and Niv BachnoffOrganisationOmnix MedicalPhosphatases rise from the ashes
Interviewee/ContributorGerhard MüllerOrganisationAnavo Therapeutics BVSwiss biotech attracted record financing in 2020
Interviewee/ContributorJane MorrisonOrganisationMedNous